Mind Medicine (MindMed) (MNMD) News Today $9.57 -0.14 (-1.44%) Closing price 04:00 PM EasternExtended Trading$9.78 +0.21 (+2.14%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock MNMD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from BrokeragesSeptember 17 at 2:29 AM | marketbeat.comMindMed Announces New Employee Inducement GrantsSeptember 8, 2025 | businesswire.comAlly Bridge Group NY LLC Has $2.28 Million Stake in Mind Medicine (MindMed) Inc. $MNMDSeptember 5, 2025 | marketbeat.comJournal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of ...September 4, 2025 | finance.yahoo.comJournal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)September 4, 2025 | businesswire.comDRW Securities LLC Takes Position in Mind Medicine (MindMed) Inc. $MNMDSeptember 4, 2025 | marketbeat.comPEAK6 LLC Cuts Holdings in Mind Medicine (MindMed) Inc. $MNMDSeptember 3, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (MNMD)’s MM120 Earns FDA Breakthrough Status in Anxiety TreatmentSeptember 2, 2025 | finance.yahoo.comMind Medicine (MindMed) Inc. $MNMD Shares Purchased by Wellington Management Group LLPSeptember 2, 2025 | marketbeat.comNuveen LLC Purchases Shares of 266,051 Mind Medicine (MindMed) Inc. $MNMDSeptember 1, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 30,052 Shares of Mind Medicine (MindMed) Inc. $MNMDSeptember 1, 2025 | marketbeat.comMindMed to Participate in September Investor ConferencesAugust 28, 2025 | financialpost.comFMind Medicine (MindMed) (NASDAQ:MNMD) Reaches New 1-Year High - Here's WhyAugust 27, 2025 | marketbeat.comMindMed Reports Strong Phase 3 Trial Progress and Leadership AppointmentAugust 25, 2025 | theglobeandmail.comVirtu Financial LLC Buys New Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)August 18, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Hits New 52-Week High - Here's What HappenedAugust 13, 2025 | marketbeat.comIf You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have TodayAugust 12, 2025 | fool.comCould This Psychedelic Drug Stock Be a Top Buy for 2026?August 8, 2025 | msn.comCould This Psychedelic Drug Stock Be a Top Buy for 2026?August 8, 2025 | msn.comHC Wainwright Has Negative Outlook for MNMD Q3 EarningsAugust 7, 2025 | marketbeat.comRoth Capital Brokers Reduce Earnings Estimates for MNMDAugust 7, 2025 | marketbeat.com1 Reason to Buy MindMed (MNMD)August 7, 2025 | fool.comFY2028 Earnings Estimate for MNMD Issued By HC WainwrightAugust 6, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 10.9% - Time to Buy?August 5, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by OppenheimerAugust 5, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Issues Earnings ResultsAugust 3, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Given Buy Rating at Chardan CapitalAugust 2, 2025 | marketbeat.comMindMed (MNMD) Q2 Net Loss Jumps 625%August 1, 2025 | fool.comMind Medicine (MindMed) Inc. (MNMD) Q2 2025 Earnings Call TranscriptJuly 31, 2025 | seekingalpha.comMindMed Reports Q2 2025 Financial Results and Business UpdatesJuly 31, 2025 | businesswire.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Recommendation of "Buy" by AnalystsJuly 29, 2025 | marketbeat.comCerity Partners LLC Invests $284,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)July 28, 2025 | marketbeat.comMind Medicine (MindMed) (MNMD) Expected to Announce Earnings on ThursdayJuly 26, 2025 | marketbeat.comMind Medicine: Heading In The Right DirectionJuly 24, 2025 | seekingalpha.comMindMed to Report Second Quarter 2025 Financial Results on July 31, 2025July 24, 2025 | businesswire.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 11.7% - What's Next?July 21, 2025 | marketbeat.comMindMed Announces New Employee Inducement GrantsJuly 14, 2025 | businesswire.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Moloney Securities Asset Management LLCJuly 12, 2025 | marketbeat.comCapital Advisors Inc. OK Makes New Investment in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)July 8, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by BrokeragesJuly 4, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Insider Sells $53,366.40 in StockJune 27, 2025 | insidertrades.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Insider Daniel Karlin Sells 7,848 SharesJune 26, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Insider Mark Sullivan Sells 11,491 SharesJune 26, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) CEO Robert Barrow Sells 26,491 SharesJune 26, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 5.4% - What's Next?June 25, 2025 | marketbeat.comMNMD Mind Medicine (MindMed) Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.3% - Here's WhyJune 18, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 4.8% - Here's WhyJune 11, 2025 | marketbeat.comEquities Analysts Offer Predictions for MNMD FY2026 EarningsJune 10, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Two Sigma Investments LPJune 5, 2025 | marketbeat.com Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MNMD Media Mentions By Week MNMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNMD News Sentiment▼1.710.92▲Average Medical News Sentiment MNMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNMD Articles This Week▼23▲MNMD Articles Average Week Get the Latest News and Ratings for MNMD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Mind Medicine (MindMed) and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MOR News IMVT News NAMS News HCM News OGN News BHC News KNSA News CGON News ALVO News CPRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNMD) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
